Table 5B.

Network meta-analysis of the efficacy of TUG.

SP-HI-RT	NA	NA	NA	NA	NA	−4.80 (−6.08; −3.52)
−4.29 (−5.65; −2.92)	LP-HI-AE	NA	NA	NA	−0.44 (−1.16; 0.27)	−0.54 (−1.11; 0.03)
−4.41 (−5.92; −2.90)	−0.12 (−1.07; 0.83)	SP-HI-AE	NA	NA	NA	−0.39 (−1.20; 0.41)
−4.61 (−6.05; −3.18)	−0.33 (−1.15; 0.50)	−0.21 (−1.25; 0.84)	LP-HI-AE	NA	NA	−0.19 (−0.85; 0.47)
−4.72 (−6.14; −3.29)	−0.43 (−1.24; 0.37)	−0.31 (−1.34; 0.72)	−0.10 (−1.02; 0.81)	LP-MI-RT	NA	−0.08 (−0.72; 0.55)
−4.76 (−6.16; −3.37)	−0.48 (−1.04; 0.08)	−0.36 (−1.34; 0.63)	−0.15 (−1.02; 0.71)	−0.05 (−0.90; 0.80)	LP-HI-RT	0.00 (−0.72; 0.72)
$\text{−4.80 (−6.08; −3.52)}$	$\text{−0.52 (−1.01; −0.02)}$	$\text{−0.39 (−1.20; 0.41)}$	$\text{−0.19 (−0.85; 0.47)}$	$\text{−0.08 (−0.72; 0.55)}$	$\text{−0.04 (−0.60; 0.52)}$	CON